Bankers Petroleum advises of BNK.WT Warrant expiry
|
| Posted
:
Tue, 03 Nov 2009 17:49:20 GMT |
| Author
:
Bankers Petroleum Ltd. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
CALGARY, Nov. 3 Bankers-Pet-warrnt-ex
CALGARY, Nov. 3 /PRNewswire-FirstCall/ - Bankers Petroleum Ltd. ("Bankers" or the "Company") (TSX: BNK, AIM: BNK) hereby notifies all holders of its 2009 Warrants (TSX: BNK.WT, AIM: BNKW) (CUSIP: 066286 13 9, ISIN: CA 0662861396) that they must be tendered for exercise before the deadline of November 10, 2009 (1pm Toronto time). Each 2009 Warrant entitles the holder to purchase one common share at a subscription price of $2.49 per share. 2009 Warrants not tendered for exercise prior to the deadline will expire and be void and of no value.
All exercise notices should be directed to the Company's transfer agent, Computershare Investor Services Inc., as stipulated in the 2009 Warrant. 2009 Warrant investors are advised that CDS Inc. and/or investment dealers through which 2009 Warrants are held may impose earlier deadlines for the exercise of 2009 Warrants and holders of 2009 Warrants should consult with their investment dealers or stockbrokers to ensure 2009 Warrants are tendered for exercise prior to any such shorter deadline.
To clarify, this deadline only applies to Bankers' 2009 Warrants. The 2012 Warrants (BNK.WT.A) (CUSIP: 066286 14 7, ISIN: CA 0662861479) warrants will continue to trade on the Toronto Stock Exchange until their expiry on March 1, 2012. The 2012 Warrants entitle the holder to purchase one common share at a subscription price of $2.37 per share.
At September 30, 2009, the Company has 225,383,142 common shares outstanding, 12,302,447 options to purchase common shares, 3,165,117 2009 Warrants, 4,873,667 2012 Warrants and 1,266,667 unlisted common share purchase warrants.
The 2009 Warrants will be cancelled to trading on AIM with effect from 8:00 am on November 11, 2009.
About Bankers Petroleum Ltd.
Bankers Petroleum Ltd. is a Canadian-based oil and gas exploration and production company focused on developing large oil and gas reserves. In Albania, Bankers operates and has the full rights to develop the Patos-Marinza heavy oil field and has a 100% interest in the Kucova oil field. Bankers' shares are traded on the Toronto Stock Exchange and the AIM Market in London, England under the stock symbol BNK.
SOURCE Bankers Petroleum Ltd.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Inmarsat Completes Strategic Acquisition Focused on Government Services Business
LONDON, November 23 -- Inmarsat plc (LSE: ISAT),
the world's leading provider of global mobile satellite communications
services, today announces the acquisition of the business and assets of
Segovia, Inc. ("Segovia"). Bas...
GoldenSource Market Leadership Recognised in Financial News Tech21 List
LONDON, November 23 /PRNewswire/ -- GoldenSource has been recognised as a
leading innovator in financial markets technology by Financial News in its
4th annual Tech 21 list of innovators and market leaders for the 21st century.
GoldenSource wa...
Advanced ID Corp. Completes Repayment of La Jolla Cove Funding CALGARY, AB -- 11/23/09 --
Advanced ID Corporation (OTCBB: AIDO) a
leading developer of RFID solutions for supply chain applications, fleet
operations, animal tracking and tire management announces today that it has
fulfilled the terms of the Sept..
Research and Markets: 2009 Plimsoll Analysis - Abnormal Load Haulage - a Comprehensive Profile of 80 Companies Operating in the UK Market DUBLIN -
Research and Markets (
Aesthetic Plastic Surgery: The Next Generation Symposium Launches in NYC NEW YORK -
Aesthetic Plastic Surgery: The Next Generation Symposium will be held
from December 4-6 at the Waldorf Astoria, announces Z. Paul Lorenc, MD,
FACS, New York aesthetic plastic surgeon and Chairman of the APSSNY.
The CME-accredited three-day interactive conference, h
MedPro Safety Products Reports Recent Progress LEXINGTON, Ky. -
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development
and marketing of passive needlestick injury prevention technology, today
reported on the Company’s recent progress.
The recent highlights include:
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist...
|
|
|
|
|
|
|
|
|